- Accueil
- mcv4
- Risk of Guillain–Barré syndrome after meningococcal conjugate vaccination - Velentgas - 2012 - Pharmacoepidemiology and Drug Safety - Wiley Online Library
Risk of Guillain–Barré syndrome after meningococcal conjugate vaccination - Velentgas - 2012 - Pharmacoepidemiology and Drug Safety - Wiley Online Library
4.5 (611) · € 22.99 · En Stock
Cureus, Guillain-Barré Syndrome Following the Administration of Adenovirus Vector-Based COVID-19 Vaccine
Frontiers Intensive Care and Treatment of Severe Guillain–Barré Syndrome
Guillain Barre — Maimonides Emergency Medicine Residency
Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination
Availability of secondary healthcare data for conducting pharmacoepidemiology studies in Colombia: A systematic review - Franco - 2020 - Pharmacology Research & Perspectives - Wiley Online Library
Risk of Guillain–Barré syndrome after meningococcal conjugate vaccination - Velentgas - 2012 - Pharmacoepidemiology and Drug Safety - Wiley Online Library
Internal Medicine Board Review: Guillian Barre Syndrome
Guillain–Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis
Current treatment practice of Guillain-Barré syndrome
Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination
Meningococcal vaccine - Wikipedia
Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial
No risk of Guillain-Barré syndrome found after meningococcal conjugate vaccination in two large cohort studies
Investigating Guillain-Barre Syndrome and Vaccines: Is There a Link?
